KEIFER RICHARDSON: Open Payments
NPI 1174031660 · AUGUSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,427 in 98 payments from 23 companies in 2025. Trend: 2023 $2,608 · 2024 $3,288 · 2025 $2,427
Food & beverage: $2,427
| Company | Payments | Amount |
|---|---|---|
| BETA BIONICS, INC. | 10 | $386 |
| Corcept Therapeutics | 11 | $349 |
| Mannkind Corporation | 11 | $276 |
| SANOFI-AVENTIS U.S. LLC | 6 | $196 |
| Amgen Inc. | 10 | $167 |
| Novo Nordisk Inc | 12 | $164 |
| Lilly USA, LLC | 7 | $161 |
| Madrigal Pharmaceuticals | 2 | $86 |
| Ascendis Pharma Endocrinology Inc | 4 | $85 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $70 |
Products named: iLet Bionic Pancreas, Korlym, AFREZZA, TZIELD, Ozempic, MOUNJARO, TEPEZZA, REZDIFFRA.
Industry payments across GA — which companies pay providers there.
